Search

everythinglearnresearchcommunity

for

Search:↓

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Venlafaxine can cause hair loss, which stops after discontinuation.

A thorough, team-based approach and clear communication improve outcomes in complex neuropsychiatric lupus cases.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Shift work disrupts the body's natural clock, leading to health problems.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Caffeine can damage hearing cells and affect hearing recovery after ear trauma.

Taking too much vitamin E caused a young man's blood clotting problems, which improved after he stopped the vitamin E and got treatment.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

Many displaced schoolchildren in Cameroon are malnourished, with high rates of thinness, stunting, underweight, and deficiencies in iron and protein.

Alopecia greatly affects Greek women's daily life, relationships, and self-image, with mixed social support and dissatisfaction with treatments.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Iron deficiency can cause psychiatric symptoms that improve with proper treatment.

The new follicular unit extraction treatment effectively treats severe hair loss in Asian men, giving natural-looking results with few side effects.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Bariatric surgery can cause serious mineral deficiencies, requiring better patient education and monitoring.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.